The intersection of genes and environment: Development of pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia and stimulant exposure

Chest

Volumn 141, Issue 6, 2012, Pages 1598-1600

  Ayala, Estela ^a   Kudelko, Kristina T ^a   Haddad, Francois ^a   Zamanian, Roham T ^a   De Jesus Perez, Vinicio ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; ENDOGLIN; METHAMPHETAMINE; SILDENAFIL;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 9; COMPUTER ASSISTED TOMOGRAPHY; DRUG ABUSE; ENDOGLIN GENE; ENVIRONMENTAL EXPOSURE; EPISTAXIS; EXON; FAMILY HISTORY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEART FAILURE; HETEROZYGOSITY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; TELANGIECTASIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84862003010     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1402     Document Type: Article

References (4)

1. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43(2):97-110. (Pubitemid 43262964)
2. Cottin V, Dupuis-Girod S, Lesca G, Cordier JF. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease). Respiration. 2007;74(4):361-378. (Pubitemid 47093147)
3. Girerd B, Montani D, Coulet F, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med. 2010; 181(8):851-861.
4. Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest. 2006;130(6):1657-1663. (Pubitemid 46033416)